See also this year's filing and all EDGAR filings for this company.
PDF Report 0001012477_2023_AVADEL_PHARMACEUTICALS_PLC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001012477, AVADEL PHARMACEUTICALS PLC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 100,843,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 16,836,000 |
| 2 | PropertyPlantAndEquipmentNet | 839,000 |
| 3 | remainder_Assets | 14,267,000 |
| 4 | LiabilitiesCurrent | 55,793,000 |
| 5 | LiabilitiesNoncurrent | 98,137,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 74,516,000 |
| 9 | ResearchAndDevelopmentExpense | 20,700,000 |
| 10 | remainder_Expenses | 41,712,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -536,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,401,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 132,785,000 |
| 1 | Liabilities | 153,930,000 |
| 2 | Expenses | 136,928,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -21,145,000 |
| 5 | NetIncome | -137,464,000 |
| 6 | ComprehensiveNetIncome | -138,664,500 |
| 7 | BaseVar | 213,290,000 |
| 8 | EconomicCapitalRatio | -1.22 |
Edgar->Model Mapping
Feature Distribution
Change over Time
